Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...
U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
3don MSN
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...
Medicare is set to negotiate the prices of 15 more drugs. Medicines that will probably be on the list are used for conditions ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam. Novo shares fell as much as 4.6% to a seven-month low on Friday after a JPMorgan Chase & Co. analyst ...
Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the ...
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback